spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

PHARM Connect Congress 2019

Pharm Connect Congress 2019

12-13 March 2019
Budapest Congress Center, Hungary

PHARM Connect Congress is the premier networking business event dedicated to pharmaceutical and biotechnology innovations and trends from development through commercialisation in Central and Eastern Europe.

The organiser - TEG The Events Group - cordially welcome all lead business professionals, academicians, researchers and peers from the field of pharmaceutical manufacturing and biotechnology to participate in the upcoming Congress.

Listen to motivating keynotes from thought leaders

The two-day gathering is going to be a great event to look forward to for its enlightening presentations and excellent panel discussions directed by well-known university professors and experts from Gedeon Richter, Novartis, Sanofi, Teva, Belupo Pharmaceuticals. The programme for this year will revolve around the theme of Personalised Medicine - together with it’s possible dangers and future potentials -, the data integrity from a manufacturer and an inspector view, the serialization with several best practice solutions, the lean principles in the highly regulated pharmaceutical industry, thus relaying the most cutting-edge findings from the field of pharmaceutical manufacturing. 

Network with industry peers

The event offers the perfect setting for solution providers to present their products and services directly to key decision makers and C-level executives playing a vital role in the pharmaceutical industry in Central Eastern Europe.

It will also prove to be a brilliant open door and an outstanding opportunity for businesses, company representatives and institutes to cooperate with potential business partners who are keen on expanding their Central Eastern European market reach. The easy to use TEG Meeting Scheduler website is providing each participant with an online platform to customise their agenda with one-to-one meetings, case study or keynote presentations and plant excursions. The online tool helps to focus on specific needs and interests, along with connecting, exchanging and matching ideas.

How to participate?

To get more details about the benefits, feel free to ask for an event brochure. Interested individuals and company representatives can confirm their participation by registering for the event along with their colleagues at www.pharmconnect.eu 

Registration https://goo.gl/r9Y1Zk

For further enquires please contact directly: info@tegevents.eu

phone +36 1 219 5725
email info@tegevents.eu
web pharmconnect.eu/
email Budapest Congress Center, Hungary
 
Print this page
Send to a friend
   
Banner of Bio Trinity_Events_Page on Samedan
spacer
Industry Events

World Advanced Therapies & Regenerative Medicine Congress 2019

15-17 May 2019, Business Design Centre, London

The World Advanced Therapies & Regenerative Medicine Congress is an exhibition and conference that has grown to become one of the best and most established cell and gene events in the world today.     The 2019 edition will be in its 14th year and it continues to grow and attract a large audience of biotech, pharma, start-ups, investors, research and technology companies from around the world. The conference and exhibition will host over 1000 attendees, 250 speakers and 80 exhibition booths. Over 500 different global companies are represented every year at this event. 
More info >>

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>


News and Press Releases

Envigo launches PATHWAY an optimized safety assessment solution to enable first in human clinical trials

11 March 2019, East Millstone, N.J. – Envigo, a leading provider of non-clinical contract research services and research models, announced today the launch of PATHWAY – an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials. PATHWAY is designed to manage the complexity of the entire safety assessment process on behalf of the company’s pharmaceutical and biotechnology customers by integrating safety assessment study types and bioanalytical support with scientific and regulatory consulting, program design and project management.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement